Envista (NYSE:NVST) Issues Quarterly Earnings Results

Envista (NYSE:NVST) issued its quarterly earnings data on Wednesday. The company reported $0.24 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.23 by $0.01, Zacks reports. Envista had a negative net margin of 53.42% and a positive return on equity of 3.76%. Envista updated its FY 2025 guidance to 0.950-1.050 EPS.

Envista Stock Performance

NYSE NVST traded down $0.69 during trading hours on Friday, hitting $21.11. 851,831 shares of the company’s stock traded hands, compared to its average volume of 2,216,298. The business’s fifty day moving average price is $19.96 and its two-hundred day moving average price is $19.12. The firm has a market capitalization of $3.63 billion, a P/E ratio of -2.72, a P/E/G ratio of 1.82 and a beta of 1.34. Envista has a 52 week low of $15.15 and a 52 week high of $23.06. The company has a current ratio of 2.08, a quick ratio of 1.77 and a debt-to-equity ratio of 0.42.

Wall Street Analyst Weigh In

Several research firms recently weighed in on NVST. Jefferies Financial Group raised their target price on shares of Envista from $20.00 to $22.00 and gave the company a “hold” rating in a research note on Thursday, January 23rd. Leerink Partners upgraded Envista from an “underperform” rating to a “market perform” rating and boosted their price target for the stock from $16.00 to $23.00 in a report on Thursday, October 31st. Piper Sandler increased their price objective on shares of Envista from $17.00 to $18.00 and gave the stock a “neutral” rating in a research report on Monday. Needham & Company LLC restated a “hold” rating on shares of Envista in a research note on Thursday. Finally, Mizuho started coverage on shares of Envista in a research note on Wednesday, December 4th. They issued an “underperform” rating and a $20.00 price objective for the company. Two investment analysts have rated the stock with a sell rating, ten have given a hold rating and three have given a buy rating to the stock. According to MarketBeat, Envista has a consensus rating of “Hold” and an average target price of $20.21.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.